Skip to main content
. 2018 Oct 16;320(15):1570–1582. doi: 10.1001/jama.2018.14619

Table 2. Cumulative Incidence Rates and 95% CIs for Macrovascular Disease Outcomes in Surgical Patients and Matched Nonsurgical Patientsa.

Incidence Rate (95% CI)
1 y 3 y 5 y 7 y
Surgical Group Nonsurgical Group Surgical Group Nonsurgical Group Surgical Group Nonsurgical Group Surgical Group Nonsurgical Group
Composite Index of Incident Macrovascular Diseaseb 0.5 (0.3-0.7) 1.1 (0.9-1.3) 1.1 (0.8-1.4) 2.6 (2.4-2.9) 2.1 (1.6-2.5) 4.3 (3.9-4.7) 3.2 (2.5-3.9) 6.2 (5.6-6.7)
Incident cerebrovascular disease 0.2 (0.1-0.3) 0.4 (0.3-0.4) 0.3 (0.2-0.5) 1 (0.8-1.1) 0.7 (0.4-0.9) 1.7 (1.5-1.9) 1.1 (0.7-1.6) 2.3 (1.9-2.6)
Incident coronary artery disease 0.3 (0.2-0.5) 0.7 (0.6-0.9) 0.9 (0.6-1.1) 1.8 (1.6-2) 1.6 (1.2-2) 2.8 (2.5-3.1) 2.3 (1.7-2.9) 4.2 (3.7-4.7)
Death (post hoc analysis) 0.4 (0.2-0.5) 0.9 (0.7-1) 0.9 (0.6-1.1) 2.7 (2.4-3) 1.3 (1-1.7) 4.5 (4.1-4.8) 2.0 (1.5-2.5) 6.4 (5.8-7)
a

Patients were matched on age, sex, body mass index, site, insulin use, hemoglobin A1c level, observed diabetes duration, and number of days of health care utilization in the 7 to 24 months prior to index date.

b

The Composite Index of Incident Macrovascular Disease indicates the first occurrence of cerebrovascular or coronary artery disease event.